Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.890
+0.050 (1.76%)
At close: May 8, 2025, 4:00 PM
2.330
-0.560 (-19.38%)
Pre-market: May 9, 2025, 8:50 AM EDT

Protalix BioTherapeutics Revenue

In the year 2024, Protalix BioTherapeutics had annual revenue of $53.40M, down -18.47%. Protalix BioTherapeutics had revenue of $18.22M in the quarter ending December 31, 2024, with 73.74% growth.

Revenue (ttm)
$53.40M
Revenue Growth
-18.47%
P/S Ratio
3.93
Revenue / Employee
$250,700
Employees
213
Market Cap
225.51M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202453.40M-12.10M-18.47%
Dec 31, 202365.49M17.86M37.48%
Dec 31, 202247.64M9.29M24.22%
Dec 31, 202138.35M-24.55M-39.03%
Dec 31, 202062.90M8.21M15.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.